Yap/Taz Deletion in Gli+ Cell-Derived Myofibroblasts Attenuates Fibrosis

Ming Liang1,2, Michael Yu2, Ruohan Xia2

  • 1Department of Nephrology, Guangzhou First People's Hospital, Guangzhou Medical University, Guangzhou, China; and.

Insights

Kidney fibrosis is driven by tissue stiffness activating the mechanosensor Yap (yes-associated protein), which transforms fibroblasts into myofibroblasts. Targeting this Yap-ECM interaction offers potential anti-fibrosis therapies.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Biomedical Engineering

Background:

  • Kidney fibrosis, characterized by increased extracellular matrix (ECM) and tissue stiffness, arises from incompletely understood molecular pathways.
  • The transcriptional coactivators Yap (yes-associated protein) and Taz (transcriptional coactivator with PDZ-binding motif) are known mechanosensors implicated in kidney myofibroblast regulation.

Purpose of the Study:

  • To investigate the hypothesis that kidney fibrosis development is dependent on Yap-induced activation and proliferation of kidney fibroblasts.
  • To elucidate the role of Yap as a tissue mechanosensor in kidney fibrosis.

Main Methods:

  • Utilized mouse models of unilateral ureteral obstruction (UUO) and a UUO-release model.
  • Employed cultured fibroblasts, Yap/Taz signaling inhibition (verteporfin), and Gli1+-cell-specific Yap/Taz knockout.
  • Assessed fibroblast-to-myofibroblast transformation, ECM production, and interstitial fibrosis.

Main Results:

  • Yap expression increased in renal fibroblasts post-UUO, correlating with interstitial fibrosis.
  • Inhibition of Yap/Taz signaling blocked TGF-β1-induced fibroblast activation and ECM production.
  • Constitutive Yap activation promoted fibroblast transformation and ECM production independently of TGF-β1.
  • Fibroblasts on stiff ECM transformed into myofibroblasts via Yap activation, even without TGF-β1.
  • Verteporfin treatment and Yap/Taz knockout in mice reduced or reversed UUO-induced fibrosis, ECM deposition, and myofibroblast accumulation.

Conclusions:

  • Yap acts as a critical kidney mechanosensor activated by ECM, driving fibroblast-to-myofibroblast transformation and contributing to kidney fibrosis.
  • A feed-forward loop between Yap/Taz and ECM promotes kidney fibrosis.
  • Targeting the Yap-ECM interaction presents a potential therapeutic strategy for anti-fibrosis treatments.